TLR3 and pneumococcal pneumonia: In the end, we studied whether the immunization protocol including the PSPF and the mucosal adjuvants Cp 090104 and BLPs could influence the resistance of the mice to secondary pneumococcal pneumonia produced after the inflammatory lung damage triggered by TLR3 activation.